About Us
InnoDev Partners understands that drug development requires more than technical expertise - it demands strategic vision, creative problem-solving, and a deep understanding of sponsor needs.
Our dedicated team excels at navigating complex development challenges while maintaining focus on commercial success. Through our collaborative approach and commitment to excellence, we help transform promising compounds into approved therapies. Our experience spans the entire development spectrum, ensuring efficient progression from early-stage development through regulatory approval and market launch.
Leadership Team
Team Experience Covers Entire Development Process
-
Michelle Usher, RAC
-
Tim Costello, PhD
-
Gail McIntyre, PhD, DABT
-
Dave Prohaska, BS
-
Kim Hawkins, PhD
-
Carolina Petrini, MBA
-
Mike Davenport, PhD
Years In Drug Development
25+
Average years of industry experience
4+
Products Launched, Products Licensed
C-Suite
Executives – Public & Private Companies
Expertise
Across Disease Areas
50+
Regulatory Submissions
40+
Publications